Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.
Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S, Michalski CW, Kleeff J, Schnieke A, Schmid RM, Saur D, Schneider G.
Conradt L, et al.
Neoplasia. 2011 Nov;13(11):1026-34. doi: 10.1593/neo.111016.
Neoplasia. 2011.
PMID: 22131878
Free PMC article.